TREM2 signaling in cardiovascular disease: macrophage heterogeneity, timing, and therapeutic opportunity
Journal of Advanced Research · 2026-11 · 89 · 1093-1115
DOI: 10.1016/j.jare.2026.08.040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Advanced Research, 2026-11. Verfasst von Ke Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Component-based Chinese Medicine & Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae for the Ministry of…. Hauptthemen laut MEDLINE: Membrane Glycoproteins, Receptors, Immunologic, Macrophages, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tianjin Municipal Education Commission, National Natural Science Foundation of China, National Major Science and Technology Projects of China.
Abstract (Originalsprache)
BACKGROUND: Cardiovascular diseases remain the leading cause of global morbidity and mortality, with pathogenesis extending beyond hemodynamic derangements to involve chronic, maladaptive immune-metabolic crosstalk. Macrophage functional identity has evolved beyond the M1/M2 paradigm toward a model of high heterogeneity and dynamic plasticity, wherein Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) serves as a pivotal molecular hub. AIM OF REVIEW: This review systematically delineates the spatiotemporal dynamics and functional duality of TREM2+ macrophages across major cardiovascular conditions, including atherosclerosis, myocardial infarction, heart failure and sepsis-induced cardiomyopathy. It further evaluates the current evidence and limitations of soluble TREM2 (sTREM2) as a candidate biomarker and critically appraises translational strategies targeting this pathway. KEY SCIENTIFIC CONCEPTS OF REVIEW: TREM2 integrates lipid sensing, efferocytosis, metabolic reprogramming, and immune modulation to exert highly context-dependent effects. In early disease stages, TREM2+ macrophages participate in lipid accumulation and inflammation initiation, whereas in later phases, they contribute to plaque stabilization, tissue repair coordination and microenvironmental homeostasis. sTREM2 may serve as a dynamic indicator of macrophage activation and functional transition, but its clinical utility for risk stratification and therapeutic monitoring remains investigational. Translational approaches include agonistic antibodies, small-molecule agonists, gene/RNA-based therapies, and localized delivery systems. However, clinical progress is challenged by profound context dependency, sexual dimorphism, undefined therapeutic windows, and the absence of cardiovascular-specific clinical validation. Future advancement requires integrating multiomics technologies, biomarker-guided trials, and systems biology to move TREM2 from mechanistic insight toward precision cardiovascular immunomodulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Component-based Chinese Medicine & Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae for the Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianji…
- Tianjin Key Laboratory of Acute Abdomen Disease-Associated Organ Injury and ITCWM Repair, Institute of Integrative Medicine of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin Medical University, 8 Changjiang…
Förderung
- Tianjin Municipal Education Commission
- National Natural Science Foundation of China
- National Major Science and Technology Projects of China
- National Science and Technology Major Project
Zitieren
APA
Yang, K., Ma, X., Wang, B., Fan, A., Gao, H., Yang, Y., Li, H., Zhu, X., Hu, W., Ni, J., Zhang, H., Li, T., Li, L., & Fan, G. (2026). TREM2 signaling in cardiovascular disease: macrophage heterogeneity, timing, and therapeutic opportunity. Journal of Advanced Research, 89, 1093-1115. https://doi.org/10.1016/j.jare.2026.08.040
Vancouver
Yang K, Ma X, Wang B, Fan A, Gao H, Yang Y, et al. TREM2 signaling in cardiovascular disease: macrophage heterogeneity, timing, and therapeutic opportunity. Journal of Advanced Research. 2026;89:1093-1115. doi:10.1016/j.jare.2026.08.040
BibTeX
@article{Yang2026,
author = {Yang, Ke and Ma, Xuefang and Wang, Binyan and Fan, Aodi and Gao, Haohao and Yang, Yakun and Li, Haixia and Zhu, Xiangyu and Hu, WeiYing and Ni, Jingyu and Zhang, Han and Li, Tian and Li, Lan and Fan, Guanwei},
title = {TREM2 signaling in cardiovascular disease: macrophage heterogeneity, timing, and therapeutic opportunity},
journal = {Journal of Advanced Research},
year = {2026},
volume = {89},
pages = {1093--1115},
doi = {10.1016/j.jare.2026.08.040}
}
EUVIMED